FolioLantern
BAXBaxter International · Insider ownership research

Baxter International insiders: what they own and what they did with it

None of it through sales. No officer or director reported an open-market sale in this period.

Updated Oct 8, 2026 from SEC filings · covers Oct 9, 2025 to Oct 8, 2026
0
buyers among officers and directors, past 12 months
0 of 26
officers and directors sold shares, past 12 months
Recent activity · past 30 days, Sep 9, 2026 to Oct 8, 2026

No officer or director trades were reported for the past 30 days. The most recent before that:

Sep 2, 20262 executives had 56K shares ($1.4M) withheld by the company for taxes (not a market sale). That is between 6.7% and 9.5% of each person's total stake held that day.
WhoSharesPrice% of total stakeTotal stake afterTrade dateFiled
Andrew Hider
President and CEO, Director
54,276$25.709.5%516KSep 2, 2026Sep 3, 2026
Julie Foster
President, Front Line Care
2,098$25.706.7%29KSep 2, 2026Sep 3, 2026

"% of total stake" is the shares in this event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings don't reconcile, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Is this normal? Less than usual: no sales, against a 5-year average of 62K shares a year. 0 insiders sold; the average is 3 a year. Year by year
Latest filing: Filed Sep 3 for a tax withholding on Sep 2. Andrew Hider had 54K shares withheld by the company for taxes. Filing
41 SEC ownership filings in the period · See the evidence

What stands out

Tax withholding outweighed market sales: the company withheld $2.8M of officers' and directors' shares for taxes, against $0 sold on the open market. The largest was Andrew Hider ($1.4M withheld).Largest withholding, Sep 2, 2026

Percentages cover 19 of 26 officers and directors. 7 are left out

i
Left out: Joel Grade, Reazur Rasul, David Rosenbloom and James Teaff (holdings couldn't be fully reconciled); Michael McDonnell, Cynthia Carlisle and Terence Rogers (held no vested shares at the start).
Disclosed company stock is not an insider's whole wealth.

Common questions

Is the Baxter International CEO selling stock?

No. Andrew Hider reported no open-market sales in the past 12 months.

Are any Baxter International insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

The evidence

The full ownership picture22 of 26 insiders fully reconciled · 25 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

InsiderHeld Oct 8, 2025SoldHeld Oct 8, 2026Still held
Andrew Hider
i
Minor difference of 2,869 shares. Small increase from dividend reinvestment. Small increase from dividend reinvestment.
President and CEO, Director
368K0518Kno sales
Vesting, gifts, unvested awards and holding lines for Andrew Hider
0shares vested or exercised
0gifted (net of own trusts)
−54Kwithheld by the company for taxes
none reportedunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value368,050518,447

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
465,651$24.17Sep 2, 2035$7.7M
488,506$20.37Feb 27, 2036$9.9M

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

Reconciliation: minor difference of 2,869 shares. Small increase from dividend reinvestment.

Joel Grade
!
Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +879 shares on Dec 1, 2025 (Direct). See the filing Sales and other transactions for Joel Grade are complete.
EVP and CFO
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Joel Grade
0shares vested or exercised
0gifted (net of own trusts)
−26Kwithheld by the company for taxes
none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +879 shares on Dec 1, 2025 (Direct). The balances below are as reported, not verified totals.

Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value222,560271,674

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
102,273$36.55Dec 1, 2033$415K
98,478$35.44Mar 6, 2035$509K
103,448$20.37Feb 27, 2036$2.1M

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

Jeanne Mason
i
Minor difference of 844 shares. Difference is under 0.5% of holdings. Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
EVP, Chief HR Officer
200K0200Kno sales
Vesting, gifts, unvested awards and holding lines for Jeanne Mason
0shares vested or exercised
0gifted (net of own trusts)
−650withheld by the company for taxes
none reportedunvested awards, start → end
  • Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value199,659199,853

Additional holdings last reported Jul 1, 2015, not confirmed since: 93,044 shares. Not included in any total or percentage on this page.

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
52,331$35.44Mar 6, 2035$271K

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

Reconciliation: minor difference of 844 shares. Difference is under 0.5% of holdings.

Alok Sonig
EVP,Group President,Pharma
128K0128Kno sales
Vesting, gifts, unvested awards and holding lines for Alok Sonig
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value128,219128,219

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
99,905$35.44Mar 6, 2035$517K

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

Reazur Rasul
!
Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +2,051 shares on Feb 9, 2026 (Direct). See the filing Sales and other transactions for Reazur Rasul are complete.
EVP,Group Pres,Healthcare
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Reazur Rasul
0shares vested or exercised
0gifted (net of own trusts)
−20Kwithheld by the company for taxes
none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +2,051 shares on Feb 9, 2026 (Direct). The balances below are as reported, not verified totals.

Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value124,614125,557

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
87,417$35.44Mar 6, 2035$452K

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

David Rosenbloom
!
Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +1,307 shares on Feb 9, 2026 (Direct). See the filing Sales and other transactions for David Rosenbloom are complete.
EVP and General Counsel
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for David Rosenbloom
0shares vested or exercised
0gifted (net of own trusts)
−13Kwithheld by the company for taxes
none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +1,307 shares on Feb 9, 2026 (Direct). The balances below are as reported, not verified totals.

Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value106,327138,216

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
58,873$35.44Mar 6, 2035$304K
64,655$20.37Feb 27, 2036$1.3M

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

James Borzi
EVP,Chief Supply Chain Officer
72K072Kno sales
Vesting, gifts, unvested awards and holding lines for James Borzi
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value71,94871,948

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
33,302$35.44Mar 6, 2035$172K

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

Steven Wallace
i
Minor difference of -1 share. Difference is under 0.5% of holdings. Started reporting during the period; starting holdings are from the Form 3.
President, Adv. Surgery
70K070Kno sales
Vesting, gifts, unvested awards and holding lines for Steven Wallace
0shares vested or exercised
0gifted (net of own trusts)
−153withheld by the company for taxes
none reportedunvested awards, start → end
  • Started reporting during the period; starting holdings are from the Form 3.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value70,28270,128

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
8,918$74.47Jun 1, 2032$0
15,352$39.06Mar 1, 2033$24K
17,840$35.44Mar 6, 2035$92K
25,862$20.37Feb 27, 2036$523K

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

Reconciliation: minor difference of -1 share. Difference is under 0.5% of holdings.

David Shafer
i
Minor difference of 522 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. New Form 3 filed 2025-02-06; earlier filings set aside.
Director
59K073Kno sales
Vesting, gifts, unvested awards and holding lines for David Shafer
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
  • New Form 3 filed 2025-02-06; earlier filings set aside.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value59,44672,804

Reconciliation: minor difference of 522 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Maria Soriano
i
Minor difference of 25 shares. Difference is under 0.5% of holdings. Started reporting during the period; starting holdings are from the Form 3.
Group Pres., ITT & Pharma.
55K075Kno sales
Vesting, gifts, unvested awards and holding lines for Maria Soriano
0shares vested or exercised
0gifted (net of own trusts)
−5.6Kwithheld by the company for taxes
none reportedunvested awards, start → end
  • Started reporting during the period; starting holdings are from the Form 3.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value54,62375,045

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
15,353$39.06Mar 1, 2033$24K
23,787$35.44Mar 6, 2035$123K
57,471$20.37Feb 27, 2036$1.2M

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

Reconciliation: minor difference of 25 shares. Difference is under 0.5% of holdings.

Stephen Oesterle
Director
36K036Kno sales
Vesting, gifts, unvested awards and holding lines for Stephen Oesterle
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value35,84735,847
Bernard Heine
i
Started reporting during the period; starting holdings are from the Form 3.
AVP, Finance InterimCAO&Cntrlr
33K033Kno sales
Vesting, gifts, unvested awards and holding lines for Bernard Heine
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Started reporting during the period; starting holdings are from the Form 3.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value32,84032,840
Julie Foster
i
Minor difference of 14 shares. Difference is under 0.5% of holdings. Started reporting during the period; starting holdings are from the Form 3.
President, Front Line Care
31K029Kno sales
Vesting, gifts, unvested awards and holding lines for Julie Foster
0shares vested or exercised
0gifted (net of own trusts)
−2.1Kwithheld by the company for taxes
none reportedunvested awards, start → end
  • Started reporting during the period; starting holdings are from the Form 3.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value31,24829,164

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
25,862$20.37Feb 27, 2036$523K

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

Reconciliation: minor difference of 14 shares. Difference is under 0.5% of holdings.

Amy Wendell
i
Minor difference of 177 shares. Difference is under 0.5% of holdings.
Director
31K044Kno sales
Vesting, gifts, unvested awards and holding lines for Amy Wendell
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value31,22244,235

Reconciliation: minor difference of 177 shares. Difference is under 0.5% of holdings.

James Teaff
!
Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +264 shares on Jun 2, 2026 (Direct). See the filing Sales and other transactions for James Teaff are complete.
President, CCS
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for James Teaff
0shares vested or exercised
0gifted (net of own trusts)
−1.1Kwithheld by the company for taxes
none reportedunvested awards, start → end
  • Started reporting during the period; starting holdings are from the Form 3.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +264 shares on Jun 2, 2026 (Direct). The balances below are as reported, not verified totals.

Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value31,12030,370

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
4,011$50.77Mar 2, 2027$0
3,436$66.31Mar 1, 2028$0
3,018$74.73Feb 28, 2029$0
3,814$75.75Mar 20, 2030$0
5,544$77.15Mar 3, 2031$0
3,101$85.23Mar 2, 2032$0
6,333$39.06Mar 1, 2033$10K
25,862$20.37Feb 27, 2036$523K

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

Cathy Smith
Director
30K030Kno sales
Vesting, gifts, unvested awards and holding lines for Cathy Smith
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value30,34530,345
Patricia Morrison
i
Minor difference of 413 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
Director
29K042Kno sales
Vesting, gifts, unvested awards and holding lines for Patricia Morrison
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value29,13742,386

Reconciliation: minor difference of 413 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

David Wilkes
i
Minor difference of 334 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
Director
24K037Kno sales
Vesting, gifts, unvested awards and holding lines for David Wilkes
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value23,90637,076

Reconciliation: minor difference of 334 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Nancy Schlichting
i
Minor difference of 308 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
Director
22K035Kno sales
Vesting, gifts, unvested awards and holding lines for Nancy Schlichting
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value21,85034,994

Reconciliation: minor difference of 308 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

William Ampofo II
i
Minor difference of 240 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
Director
17K030Kno sales
Vesting, gifts, unvested awards and holding lines for William Ampofo II
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
  • Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value17,29930,375

Additional holdings last reported Jun 29, 2023, not confirmed since: 3,811 shares. Not included in any total or percentage on this page.

Reconciliation: minor difference of 240 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Anita Zielinski
i
Minor difference of 233 shares. Difference is under 0.5% of holdings.
SVP, Interim CFO, CAO & Cntrlr
17K060Kno sales
Vesting, gifts, unvested awards and holding lines for Anita Zielinski
0shares vested or exercised
0gifted (net of own trusts)
−1.9Kwithheld by the company for taxes
none reportedunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value17,12359,714

Reconciliation: minor difference of 233 shares. Difference is under 0.5% of holdings.

Stephen Rusckowski
Director
16K016Kno sales
Vesting, gifts, unvested awards and holding lines for Stephen Rusckowski
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value16,49916,499
Jeffrey Craig
i
Minor difference of 154 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
Director
11K024Kno sales
Vesting, gifts, unvested awards and holding lines for Jeffrey Craig
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value10,67223,662

Reconciliation: minor difference of 154 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Michael McDonnell
i
Started reporting during the period; starting holdings are from the Form 3.
Director
0015Kno sales
Vesting, gifts, unvested awards and holding lines for Michael McDonnell
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Started reporting during the period; starting holdings are from the Form 3.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value014,647
Cynthia Carlisle
i
Started reporting during the period; starting holdings are from the Form 3.
Executive Vice President, CHRO
0030Kno sales
Vesting, gifts, unvested awards and holding lines for Cynthia Carlisle
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Started reporting during the period; starting holdings are from the Form 3.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock, $1 par value029,677

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
43,103$20.37Feb 27, 2036$872K

Estimate: options held × ($40.61 − strike price), using the most recent insider trade price on Form 4 (Mar 1, 2024), not a market close.

22 of 26 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (9 exactly, 13 with a minor or footnoted difference). For 4 we show sales but not holdings; the ! icon on their rows explains why. Percentages cover 19 of 26 officers and directors. Left out: Joel Grade, Reazur Rasul, David Rosenbloom and James Teaff (holdings couldn't be fully reconciled); Michael McDonnell, Cynthia Carlisle and Terence Rogers (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

Is this normal? Selling year by year5 earlier years to compare with

Less than usual: no sales, against a 5-year average of 62K shares a year. 0 insiders sold; the average is 3 a year.

12 months endingShares soldInsiders who soldProceeds
Oct 8, 2026
Latest 12 months
00$0
Oct 8, 2025
1 year earlier
00$0
Oct 8, 2024
2 years earlier
64K1$2.6M
Oct 9, 2023
3 years earlier
67K3$3.0M
Oct 9, 2022
4 years earlier
91K7$7.5M
Oct 9, 2021
5 years earlier
88K4$7.0M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty4 insiders whose holdings couldn't be fully reconciled

Joel Grade: holdings couldn't be fully reconciled (difference of 1,460 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +879 shares on Dec 1, 2025 (Direct). Filing, Dec 1, 2025

Footnote: "Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 1, 2025 from the settlement of vested restricted stock units granted on December 1, 2023. | Total includes the automatic reinvestment of dividends."

Reazur Rasul: holdings couldn't be fully reconciled (difference of 2,050 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +2,051 shares on Feb 9, 2026 (Direct). Filing, Feb 9, 2026

Footnote: "Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to Decemb"

David Rosenbloom: holdings couldn't be fully reconciled (difference of 1,306 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +1,307 shares on Feb 9, 2026 (Direct). Filing, Feb 9, 2026

Footnote: "Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to Decemb"

James Teaff: holdings couldn't be fully reconciled (difference of 321 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +264 shares on Jun 2, 2026 (Direct). Filing, Jun 2, 2026

Footnote: "Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 2, 2026, from the settlement of vested restricted stock units granted on June 2, 2025. | Total includes shares held in the Baxter's Employee Stock Plan."

Andrew Hider: minor difference of 2,869 shares. Small increase from dividend reinvestment.

Jeanne Mason: minor difference of 844 shares. Difference is under 0.5% of holdings.

Steven Wallace: minor difference of -1 share. Difference is under 0.5% of holdings.

David Shafer: minor difference of 522 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Maria Soriano: minor difference of 25 shares. Difference is under 0.5% of holdings.

Julie Foster: minor difference of 14 shares. Difference is under 0.5% of holdings.

Amy Wendell: minor difference of 177 shares. Difference is under 0.5% of holdings.

Patricia Morrison: minor difference of 413 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

David Wilkes: minor difference of 334 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Nancy Schlichting: minor difference of 308 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

William Ampofo II: minor difference of 240 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Anita Zielinski: minor difference of 233 shares. Difference is under 0.5% of holdings.

Jeffrey Craig: minor difference of 154 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Inferred rename: "Spousal Lifetime Access Trust" is treated as the same holder as "Shares by Spousal Lifetime Access Trust", because the old name was never reported again and the new one opened with the same balance (22,600 shares). Old name, new name

Inferred rename: "Shares held by Trust" is treated as the same holder as "Shares owned by Family Trust", because the old name was never reported again and the new one opened with the same balance (696 shares). Old name, new name

Inferred rename: "Thomas F. Chen Grantor Irrevocable Trust" is treated as the same holder as "Shares Owned by Thomas F. Chen Grantor Irrevocable Trust", because the old name was never reported again and the new one opened with the same balance (9,174 shares). Old name, new name

Inferred rename: "Michael F. Maloney Revocable Trust" is treated as the same holder as "Michael F. Mahoney Revocable Trust", because the old name was never reported again and the new one opened with the same balance (10,700 shares). Old name, new name

Inferred rename: "Michael F. Mahoney Revocable Trust" is treated as the same holder as "Shares owned by Michael F. Mahoney Revocable Trust", because the old name was never reported again and the new one opened with the same balance (20,397 shares). Old name, new name

Inferred typo: the share class "CommonStock, $1 par value" is treated as the same class as "Common Stock, $1 par value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Karen May, 71,054 shares): old title, new title

Inferred typo: the share class "Common Stock, $1 par valu" is treated as the same class as "Common Stock, $1 par value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Albert Stroucken, 32,965 shares): old title, new title

Inferred typo: the share class "Common Stock, $ 1 par value" is treated as the same class as "Common Stock, $1 par value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Cheryl White, 16,918 shares): old title, new title

Inferred typo: the share class "Common Stock, $1par value" is treated as the same class as "Common Stock, $1 par value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (David Scharf, 32,194 shares): old title, new title

Inferred typo: the share class "Common Stock,$1 par value" is treated as the same class as "Common Stock, $1 par value" on 2 holding lines, because the two spellings are nearly identical and each balance carried over exactly. Example (Brik Eyre, 45,561 shares): old title, new title

Inferred typo: the share class "Common Stock, $1 par valie" is treated as the same class as "Common Stock, $1 par value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Robert Felicelli, 394 shares): old title, new title

Inferred typo: the share class "Common Stock, $1 par vale" is treated as the same class as "Common Stock, $1 par value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Giuseppe Accogli, 54,310 shares): old title, new title

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology1,491 filings from SEC EDGAR, and how we read them

All 1,491 Forms 3, 4 and 5 filed for Baxter International (SEC CIK 10456) from Aug 20, 2002 to Oct 2, 2026, retrieved from SEC EDGAR on Oct 8, 2026. Prices are the ones reported in each filing, often weighted averages. 12 filings were left out because Baxter International filed them as an owner of another company's stock. 82 older filings exist only on paper and could not be read.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (77)No filing in 18 months; last reported balances, not in any total
NameLast filedLast reported balance
Heather KnightMar 10, 2025177,362 shares, last reported balance as of Mar 6, 2025
Christopher TothFeb 4, 2025105,186 shares, last reported balance as of Jan 31, 2025
Jose AlmeidaDec 17, 2024568,565 shares, last reported balance as of Dec 13, 2024
Peter WilverMay 9, 202413,267 shares, last reported balance as of May 7, 2024
Brian StevensMar 8, 202484,245 shares, last reported balance as of Mar 6, 2024
Michael MahoneyMay 4, 202340,789 shares, last reported balance as of May 2, 2023
Albert StrouckenMar 22, 202357,638 shares, last reported balance as of Mar 20, 2023
James SaccaroMar 6, 2023224,354 shares, last reported balance as of Mar 2, 2023
Cristiano FranziMar 6, 2023102,145 shares, last reported balance as of Mar 2, 2023
Jacqueline KunzlerMar 6, 202322,625 shares, last reported balance as of Mar 2, 2023
Steven FlynnMar 3, 202331,080 shares, last reported balance as of Mar 1, 2023
Peter HellmanMay 5, 202249,492 shares, last reported balance as of May 3, 2022
Thomas ChenMay 5, 202232,053 shares, last reported balance as of May 3, 2022
John ForsythApr 5, 202281,406 shares, last reported balance as of Apr 1, 2022
Giuseppe AccogliMar 4, 202276,495 shares, last reported balance as of Mar 2, 2022
Sean MartinMar 4, 202252,632 shares, last reported balance as of Mar 2, 2022
Andrew FryeMar 4, 202222,002 shares, last reported balance as of Mar 2, 2022
Thomas StallkampMay 6, 202166,012 shares, last reported balance as of May 4, 2021
James Gavin IIISep 15, 202078,275 shares, last reported balance as of Aug 3, 2020
Alex BlancoApr 1, 2020No balance on record
Third Point LLCMay 17, 2019156,771,597 shares, last reported balance as of May 16, 2019
Scott PleauApr 2, 201920,076 shares, last reported balance as of Mar 29, 2019
Brik EyreMar 4, 2019116,939 shares, last reported balance as of Feb 19, 2019
Carole ShapazianDec 17, 201828,652 shares, last reported balance as of Dec 13, 2018
Kornelis StormMar 30, 201841,520 shares, last reported balance as of Mar 28, 2018
Caroline KarpMar 7, 201812,557 shares, last reported balance as of Mar 5, 2018
Marcus SchabackerMar 8, 201765,061 shares, last reported balance as of Mar 6, 2017
Paul VibertMar 8, 2017150,493 shares, last reported balance as of Mar 6, 2017
David ScharfFeb 23, 2017205,248 shares, last reported balance as of Feb 21, 2017
Robert FelicelliJan 3, 201765,638 shares, last reported balance as of Dec 30, 2016
Uma ChowdhryMay 5, 201617,012 shares, last reported balance as of May 3, 2016
Timothy LawrenceMar 9, 201691,441 shares, last reported balance as of Mar 7, 2016
Jill SchaafMar 9, 201698,333 shares, last reported balance as of Mar 7, 2016
Sebastian BufalinoMar 7, 201641,362 shares, last reported balance as of Mar 3, 2016
Munib IslamOct 1, 2015No balance on record
Robert Parkinson Jr.Aug 13, 20151,376,717 shares, last reported balance as of Aug 11, 2015
Ludwig HantsonJun 3, 2015200,461 shares, last reported balance as of Jun 1, 2015
Gail FoslerMay 7, 201532,566 shares, last reported balance as of May 5, 2015
Blake DevittMay 7, 201519,892 shares, last reported balance as of May 5, 2015
Wayne HockmeyerMay 7, 201512,359 shares, last reported balance as of May 5, 2015
Robert HombachMar 5, 201583,031 shares, last reported balance as of Mar 3, 2015
Jean ButelFeb 13, 201542,732 shares, last reported balance as of Dec 17, 2014
Robert DavisMar 6, 2014128,146 shares, last reported balance as of Jan 29, 2014
Phillip BatchelorMar 6, 201424,632 shares, last reported balance as of Jan 29, 2014
Norbert RiedelJan 18, 201356,689 shares, last reported balance as of Jan 16, 2013
Michael BaughmanJan 18, 201330,042 shares, last reported balance as of Jan 16, 2013
Thomas ChenNov 14, 2012No balance on record
Walter BoomerMay 5, 201125,002 shares, last reported balance as of May 3, 2011
James GatlingMar 8, 2011171,166 shares, last reported balance as of Jan 19, 2011
Joseph MartinOct 27, 201016,525 shares, last reported balance as of Oct 25, 2010
Joy AmundsonMar 17, 201081,665 shares, last reported balance as of Mar 15, 2010
Bruce McGillivrayMar 17, 2010171,181 shares, last reported balance as of Mar 15, 2010
Peter ArduiniMar 17, 201068,975 shares, last reported balance as of Mar 15, 2010
Cheryl WhiteMar 17, 201031,401 shares, last reported balance as of Mar 15, 2010
Karenann TerrellMar 17, 201022,822 shares, last reported balance as of Mar 15, 2010
John GreischMar 18, 200985,474 shares, last reported balance as of Mar 16, 2009
Susan LichtensteinMar 18, 200922,562 shares, last reported balance as of Mar 16, 2009
James UttsMar 16, 2006255,401 shares, last reported balance as of Mar 14, 2006
Carlos Del SaltoSep 12, 200536,289 shares, last reported balance as of Sep 9, 2005
Karen MayJul 29, 200566,126 shares, last reported balance as of Jul 28, 2005
Lawrence GibbonsMar 16, 200521,000 shares, last reported balance as of Mar 14, 2005
Michael TuckerMay 25, 2004210,630 shares, last reported balance as of May 24, 2004
Fred TurnerMay 5, 200440,062 shares, last reported balance as of May 4, 2004
David DrohanMay 5, 200461,879 shares, last reported balance as of May 3, 2004
Brian AndersonApr 27, 2004155,427 shares, last reported balance as of Apr 26, 2004
Marla PerskyMar 30, 200450,356 shares, last reported balance as of Mar 26, 2004
Neville JeharajahDec 22, 2003134,601 shares, last reported balance as of Aug 4, 2003
John MoonDec 22, 2003No balance on record
James HurleyNov 20, 2003No balance on record
Harry Kraemer Jr.Nov 20, 2003694,896 shares, last reported balance as of Jul 30, 2003
Thomas GlanzmannNov 20, 2003No balance on record
Steven MeyerNov 20, 2003No balance on record
Jan ReedNov 20, 2003No balance on record
Thomas Sabatino Jr.Nov 20, 2003No balance on record
Gregory YoungNov 20, 2003No balance on record
Monroe TroutNo balance on record
Yuan PeiNo balance on record